These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12257563)

  • 21. A critical ('stress') evaluation of the combined ML Copper 250-short IUD in nulliparous women.
    Goldstuck ND
    Contracept Deliv Syst; 1981 Oct; 2(4):287-93. PubMed ID: 12336989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The intrauterine active disposition in the dysfunctional uterine bleeding: its action on miometrium, endometrium and vaginal epithelium].
    Ruiz-velasco V; Martinez Manatau J; Illanes Amurrio S; Romero Salinas G; Maqueo Topete M; Conde De Varges BI
    J Bras Ginecol; 1974 Oct; 78(4):417-31. PubMed ID: 12278214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histological responses of the endometrium to the IUD.
    De Brux J; Trevoux R; Chambe G
    Contracept Deliv Syst; 1981 Apr; 2(1):145-56. PubMed ID: 12336867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin levels in the cervical mucus of copper intrauterine contraceptive device users.
    Makhlouf H; Abou-gabal A; El-hefnawi N; Khalifa A
    Popul Sci; 1988; (8):19-29. PubMed ID: 12343623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statement on intrauterine devices (IUDs).
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Histological response of the endometrium to IUD's (author's transl)].
    Debrux J; Trevoux R; Chambe G
    Contracept Fertil Sex (Paris); 1980 Dec; 8(12):911-16. PubMed ID: 12310063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Structural and morphofunctional changes in the endometrium after postpartum insertion of the intrauterine device].
    Zheleznov BI; Orlova VS; Khopina AA
    Akush Ginekol (Mosk); 1982 Oct; (10):26-30. PubMed ID: 7180994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ultrastructural endometrial changes in IUD users].
    Mainero C; Bruno V; Lombardo M; Pace S; Modesti A; Simonelli L; Vecchione A
    Patol Clin Ostet Ginecol; 1985; 13(5):399-406. PubMed ID: 12315929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of copper-containing intrauterine contraceptive devices (IUCD) on growth of endometrial and cervical cells.
    Amin NS; Al-janabi NY; Banna HB; Al-tai S; Al-kateeb A; Kubba K; Al-nasiri N
    Med Sci Res; 1989 May 1-15; 17(9):433-4. PubMed ID: 12283436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinico-pathological study of Neogynon as a new oral contraceptive steroid.
    El-zenieny AH; El-kabarity H; Hafiz MA; Fikry MF
    Ain Shams Med J; 1976 Mar; 27(2):213-6. PubMed ID: 12261440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometrial cytology of IUD smears: endometrial reaction study].
    Salome N; Rezende CD; Peixoto RM; Rocha AH
    J Bras Ginecol; 1986; 96(6):263-6. PubMed ID: 12268684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fibrinolytic activity in endometrium and uterine fluid of women using intrauterine contraceptive devices].
    Lu Q
    Shengzhi Yu Biyun; 1983 Aug; 3(3):6-8. PubMed ID: 12267402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral contraceptives on the ultrastructure of the endometrium.
    Mitra PK; Roychadhuri J
    J Gynaecol Endocrinol; 1987; 3(1-4):13-5. PubMed ID: 12316565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hysteroscopic findings in complicated and non-complicated IUD users.
    El Sahwi S; Kamel M
    Adv Contracept Deliv Syst; 1992; 8(1-2):161-6. PubMed ID: 12285562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IUD-related anatomical, cytological and pathological modifications in the uterine tract (author's transl)].
    Levrier M
    Contracept Fertil Sex (Paris); 1982 May; 10(5):293-9. PubMed ID: 12338181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hysterographic study of some side effects of the copper T 200 device.
    Hefnawi FI; Hamed AF; Askalani H; Younis N; El Sheikha Z; Sherif H
    Popul Sci; 1982; (3):73-91. PubMed ID: 12266220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.